National Health Investors’ (NHI) Outperform Rating Reaffirmed at Wedbush

Wedbush reaffirmed their outperform rating on shares of National Health Investors (NYSE:NHI) in a report published on Monday morning, MarketBeat.com reports. The brokerage currently has a $88.00 target price on the real estate investment trust’s stock.

Separately, Truist Financial lowered their price target on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a report on Monday, December 23rd. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, National Health Investors presently has an average rating of “Hold” and an average target price of $84.50.

National Health Investors Price Performance

NYSE:NHI opened at $75.41 on Monday. National Health Investors has a one year low of $57.80 and a one year high of $86.13. The company has a market cap of $3.45 billion, a P/E ratio of 25.91, a P/E/G ratio of 4.42 and a beta of 1.08. The firm’s fifty day moving average price is $69.74 and its two-hundred day moving average price is $74.71. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.03. The firm had revenue of $85.75 million for the quarter, compared to the consensus estimate of $81.13 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. Equities analysts expect that National Health Investors will post 4.41 earnings per share for the current year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a $0.90 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.77%. National Health Investors’s payout ratio is 115.38%.

Institutional Trading of National Health Investors

Several hedge funds and other institutional investors have recently bought and sold shares of NHI. Quarry LP bought a new position in shares of National Health Investors during the third quarter valued at approximately $27,000. Point72 DIFC Ltd bought a new position in shares of National Health Investors during the third quarter valued at approximately $35,000. Loomis Sayles & Co. L P bought a new position in shares of National Health Investors during the third quarter valued at approximately $38,000. Assetmark Inc. raised its holdings in shares of National Health Investors by 27.8% during the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after acquiring an additional 141 shares in the last quarter. Finally, GF Fund Management CO. LTD. bought a new position in shares of National Health Investors during the fourth quarter valued at approximately $58,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.